(:NSTG)

Feb 09, 2024 08:31 am ET
Thinking about buying stock in Confluent, Dell Technologies, CleanSpark, NanoString Technologies, or Affirm?
NEW YORK, Feb. 9, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CFLT, DELL, CLSK, NSTG, and AFRM.
Feb 09, 2024 06:30 am ET
NanoString Announces Completion of Financing to Support Restructuring Process
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its existing lenders comprised of (a) $12,500,000 in new money term loans which have already been approved for funding pursuant to the February 5 interim order of the U.S. Bankruptcy court approving the credit facility, and (b) an additional $35,000,000 in new money term loans to be funded upon entry of the final order of the Court approving the credit facility, which is expected in late February. T
Feb 04, 2024 07:45 pm ET
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that steps are being taken to protect its business, customers, employees and its mission to “Map the Universe of Biology.” With support from key creditors, NanoString and certain of its subsidiaries have voluntarily initiated a chapter 11 restructuring proceeding in the United States Bankruptcy Court for the District of Delaware. Coincident with this proceeding, NanoString is exploring strategic alternatives in support
Feb 01, 2024 06:00 am ET
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel, the industry’s first si
Jan 07, 2024 03:00 pm ET
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager (SMI). The data will be highlighted at the 42nd annual J.P. Morgan Healthcare Conference 2024 in San Francisco during NanoString’s corporate presentation on
Jan 05, 2024 04:01 pm ET
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees.
Jan 04, 2024 06:00 am ET
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024.
Nov 19, 2023 06:16 pm ET
NanoString Comments on Delaware District Court Verdict
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profiler products infringe patents licensed to 10x Genomics and awarding approximately $31 million in damages, consisting of approximately $25 million of lost profits and a $6 million royalty.
Nov 09, 2023 12:00 pm ET
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today it will present at the Society for Neuroscience (SfN) annual meeting a large body of new brain research powered by its industry-leading digital spatial profiling and spatial imaging platforms.
Nov 09, 2023 06:00 am ET
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
Nov 06, 2023 04:00 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94%, principal amount of its Convertible Notes for new Senior Secured Notes due September 1, 2026 and common stock warrants.
Nov 01, 2023 05:00 am ET
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held in San Diego, CA.
Oct 10, 2023 12:06 pm ET
10x Genomics Comments on Second UPC Preliminary Injunction Decision
UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect
Oct 10, 2023 06:00 am ET
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the third quarter ended September 30, 2023, as well as a reorganization designed to accelerate the Company’s path to profitability.
Oct 03, 2023 06:00 am ET
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
A*STAR’s Genome Institute of Singapore (GIS), NanoString® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response. The new lab, called the SpACE-Dx lab (Spatial Atlas of Clinical Evolution of Disease), will harness spatial multiomic (gene and protein expression) technologies to drive research in complex diseases, with a primary focus on cancer
Sep 19, 2023 11:54 am ET
NanoString Comments on Unified Patent Court Order
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the European Unified Patent Court (UPC) granting a preliminary injunction effective immediately in 17 Member States of the European Union against NanoString’s CosMx™ Spatial Molecular Imager (SMI) products for RNA detection in NanoString’s ongoing patent dispute with 10x Genomics and Harvard:
Sep 14, 2023 06:00 am ET
NanoString to Host Virtual Spatial Genomics Summit September 19
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial G
Sep 13, 2023 06:00 am ET
NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered
NanoString Technologies (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for the GeoMx® Digital Spatial Profiler (DSP). The GeoMx IO Proteome Atlas (IPA) is the industry’s most comprehensive spatial proteomics assay, enabling spatial profiling of more than 500 immuno-oncology (IO) relevant targets from FFPE (Formalin-Fixed, Paraffin-Embedded) tissue sections.
Sep 07, 2023 06:00 am ET
NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research Organization (CRO) CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, and Sirona Dx offer global biopharma customers new access to CosMx™ SMI technology for translational drug development. These specialty CROs provide biomarker testing services for drug developers and academic research institutions.
Sep 05, 2023 06:00 am ET
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
Aug 28, 2023 05:53 am ET
NanoString Appoints Todd Garland as Chief Commercial Officer
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28, 2023.
Aug 21, 2023 06:00 am ET
NanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ Transplants
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today that a team of globally renowned researchers utilized two NanoString platforms, the nCounter® Analysis System and GeoMx® Digital Spatial Profiler, to decode the immune response following the transplantation of genetically modified pig kidneys into humans. The groundbreaking study featured in the August issue and an accompanying commentary of
Aug 08, 2023 05:00 am ET
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
Aug 03, 2023 04:00 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2023.
Jul 11, 2023 05:00 am ET
Delaware District Court Permits NanoString’s Counterclaims that 10x Genomics and Harvard Violated the Antitrust Laws
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United States District Court for the District of Delaware in NanoString’s patent litigation with 10x Genomics and President and Fellows of Harvard College. In its order, the Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirmative defense of “unclean hands” by 10x and Harvard. The ruling relates to NanoString’s claim that Harvard made a non-exclus
Jul 10, 2023 05:00 am ET
NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023.
Jun 30, 2023 04:00 pm ET
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees.
Jun 09, 2023 04:00 pm ET
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees.
Jun 08, 2023 07:01 am ET
Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics
Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis.
Jun 01, 2023 05:54 pm ET
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
Owkin, Nanostring (NASDAQ:NSTG), and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, and Charité - Universitätsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical
Jun 01, 2023 09:00 am ET
10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products
Also Files New Suit Against Vizgen's MERSCOPE Products for Patent Infringement
May 31, 2023 06:00 am ET
NanoString to Webcast Presentation from Jefferies Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023.
May 22, 2023 05:00 am ET
NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich.
May 17, 2023 04:17 pm ET
NanoString Responds to Decision of the Regional Court of Munich
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to the Regional Court of Munich’s recent decision finding that NanoString’s CosMx Spatial Molecular Imager, when used to detect RNA targets, infringes the German part of the European patent 2794928B1. The Munich court granted 10x Genomics, Inc. and President and Fellows of Harvard College the right to enforce an injunction against use of the CosMx SMI instrument for RNA detection in Germany. NanoString believes the Munich court came to an erroneous co
May 17, 2023 04:05 pm ET
10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products
10x Genomics is seeking additional injunctions to protect its intellectual property
May 03, 2023 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2023.
Apr 10, 2023 06:00 am ET
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Mar 08, 2023 04:00 pm ET
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16 new employees.
Mar 01, 2023 05:39 pm ET
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
Feb 28, 2023 04:00 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022.
Feb 23, 2023 06:00 am ET
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
Feb 14, 2023 06:00 am ET
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Feb 06, 2023 06:00 am ET
NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL. The Company is hosting the Gold Sponsor workshop on Tuesday, February 7th from 12:00-1:30pm EST. This event will also be live-streamed and interested parties can use this
Feb 02, 2023 06:00 am ET
Weill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy (SAHA) initiative, in collaboration with Weill Cornell Medicine, to create multicellular, single-cell, and sub-cellular maps of 30 non-diseased organs from a healthy and diverse population of adults.
Jan 19, 2023 06:00 am ET
NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new data generated by the CosMx™ Spatial Molecular Imager (SMI). This data was generated from formalin-fixed paraffin-embedded (FFPE) human liver samples and showcases the best-in-class data quality of the CosMx SMI. The dataset highlights CosMx SMI’s high sensitivity, with the capability to detect and quantify an average of 1,150 transcripts per cell and to maximize biological insights by detecting 676 unique genes. The dataset al
Jan 08, 2023 06:00 am ET
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2022.
Jan 03, 2023 06:00 am ET
National Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s CosMx™ Spatial Molecular Imager (SMI) has been highlighted in the January edition of National Geographic Magazine. An article entitled ‘Living Longer and Better’ highlighted research from Wake Forest University, which used the CosMx SMI to study human brain tissue from patients with Alzheimer’s disease to reveal the intricacies of human aging.
Dec 22, 2022 06:00 am ET
NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference.
Dec 13, 2022 12:24 pm ET
NanoString’s CosMx Spatial Molecular Imager Recognized by The Scientist Magazine as a Top 10 Innovation of 2022
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s CosMx™ Spatial Molecular Imager (SI) has been recognized by The Scientist magazine as one of the Top 10 Innovations of the 2022 (
Dec 06, 2022 06:00 am ET
NanoString Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first commercial shipment of the CosMx™ Spatial Molecular Imager (SMI) and the AtoMx™ Spatial Informatics Platform (SIP).
Nov 10, 2022 06:00 am ET
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
Nov 09, 2022 06:00 am ET
NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Abcam (AIM: ABC; NASDAQ: ABCM), a global life science company working together with researchers to advance science and enable faster breakthroughs, today announced the expansion of their long-standing relationship with a new agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomic solutions.
Nov 07, 2022 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2022.
Oct 13, 2022 06:00 am ET
NanoString and Visiopharm Announce Collaboration to Co-develop Integrated Workflows for GeoMx and AtoMx Spatial Biology Solutions
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Visiopharm, a world leader in AI-driven digital pathology software, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies. Together, NanoString and Visiopharm are developing integrated workflows leveraging the multiplexing capability of the GeoMx® Digital Spatial Profiler (DSP) and the AI-driven image analysis capabilities of Visiopharm. NanoString’s new
Oct 12, 2022 06:00 am ET
NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report third quarter 2022 operating results after the close of the market on Monday, November 7, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Oct 12, 2022 06:00 am ET
Spatial Imaging of 1,000 RNAs and 100 Proteins Using the CosMx Spatial Molecular Imager Published in Nature Biotechnology
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of its first paper describing the CosMx™ Spatial Molecular Imager’s (SMI) chemistry, reproducibility, and sensitivity, as well as the application of the technology to study non-small cell lung cancer and breast cancer samples in Nature Biotechnology.
Sep 07, 2022 06:00 am ET
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming financial conferences.
Aug 09, 2022 06:00 am ET
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics using the GeoMx Human Whole Transcriptome Atlas (WTA) to construct a high-resolution molecular landscape of pancreatic cancer. This paper, along with a tissue image generated using the GeoMx® Digital Spatial Profiler (DSP), is featured on the cover of the August 2022 edition of Nature Genetics.
Aug 04, 2022 04:01 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2022.
Aug 04, 2022 06:00 am ET
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
Jul 11, 2022 06:00 am ET
NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Jun 06, 2022 06:00 am ET
NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial Informatics Portal (SIP) at the Spatial Multiomic Symposium at the 2022 AGBT General Meeting in Orlando, FL. Attendees of the conference will have a chance to preview AtoMx SIP at the symposium on Monday, June 6, 2022, from noon to 4:00 pm EDT. The event will be live-streamed and in-person. Visit
Jun 02, 2022 06:00 am ET
NanoString to Unveil New Platforms and Showcase Spatial Biology Research at 2022 Advances in Genome Biology and Technology (AGBT) General Meeting
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced plans to commercially unveil the CosMx™ Spatial Molecular Imager (SMI) and its new spatial informatics portal during a Spatial Multiomic Symposium, which will be held on Monday, June 6 from noon to 4:00 pm EDT. The event will be live-streamed and held in person, and details can be found here:
May 23, 2022 06:00 am ET
NanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of customers using Illumina NextSeq™ 1000 and NextSeq™ 2000 sequencing systems and the GeoMx® Digital Spatial Profiler. The spatial analysis of whole transcriptomes combined with proteome analytes can now be simplified using this integrated, push-button run planning tool.
May 18, 2022 06:00 am ET
NanoString to Webcast Presentation from the UBS 2022 Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 2022 UBS Global Healthcare Conference.
May 10, 2022 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2022.
Apr 27, 2022 04:01 pm ET
NanoString to Release First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2022 operating results after the close of the market on Tuesday, May 10, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Apr 18, 2022 04:00 pm ET
NanoString Appoints Dr. Teresa Foy to Board of Directors
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of Dr. Teresa (Teri) Foy to the Board of Directors, effective April 18, 2022.
Apr 12, 2022 04:01 pm ET
NanoString Technologies Announces Preliminary Revenue for First Quarter of Fiscal Year 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary total product and service revenue of approximately $31 million for the first quarter. This unaudited estimate, based on management's preliminary financial analysis, is lower than the company's previous guidance for product and service revenue of $34 million to $38 million for the first quarter of 2022.
Apr 08, 2022 03:15 pm ET
NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of over 125 studies enabled by NanoString platforms that will be presented at the 2022 meeting of the American Association of Cancer Research (AACR), which will be held April 8-13, 2022.
Apr 07, 2022 06:00 am ET
NanoString Launches New nCounter Pro Analysis System
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the nCounter® Pro Analysis System, the next generation of the nCounter instrument platform. The new system requires minimal bioinformatics support and includes a new operating system, modern cybersecurity improvements, helping to keep data secure from unauthorized access, corruption or theft, and an expansive menu to support biomanufacturing and translational research.
Mar 01, 2022 04:00 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2021.
Feb 24, 2022 04:01 pm ET
NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd Annual Cowen Health Care Conference. The conference will be held virtually from March 7-9, 2022.
Feb 24, 2022 06:00 am ET
NanoString to Showcase CosMx Spatial Molecular Imager at 4th Annual Spatial Genomics Summit, Feb. 28
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the CosMx™ Spatial Molecular Imager (SMI) to occur at the fourth annual virtual Spatial Genomics Summit on Monday, Feb. 28 from 8-10 a.m. (PST).
Feb 23, 2022 06:00 am ET
NanoString Expands Partnership with Leica Biosystems to Accelerate Spatial Discoveries with Automated Workflow
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of a fully automated GeoMx® RNA protocol on BOND RX research staining systems through an expanded partnership with Leica Biosystems. The new, improved RNA protocol offers whole transcriptome profiling of Formalin-Fixed Paraffin-Embedded (FFPE), fixed frozen, or fresh frozen tissue, ultimately improving reproducibility and throughput, minimizing manual steps, and reducing hands-on time.
Feb 09, 2022 06:00 am ET
NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 11th Annual SVB Leerink Global Healthcare Conference. The conference will be held virtually from February 16-18, 2022.
Feb 07, 2022 06:00 am ET
NanoString to Release Fourth Quarter and Fiscal Year 2021 Operating Results and Host Conference Call on Tuesday, March 1, 2022
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release fourth quarter and fiscal year 2021 operating results after the close of the market on Tuesday, March 1, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Jan 10, 2022 04:01 pm ET
NanoString Reports Inducement Grant Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today reported, as required by Nasdaq Stock Market Rules, an equity inducement award to John D. Gerace, the Company’s new Chief Commercial Officer.
Jan 09, 2022 11:35 am ET
NanoString Announces Commercial Leadership Transition
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a commercial leadership transition. Chad Brown, who has served as senior vice president of Sales & Marketing since June 2017, will be shifting into a part-time senior advisor role effective April 1, before fully retiring in March 2023. John D. Gerace has been named to the position of Chief Commercial Officer effective immediately.
Jan 09, 2022 11:30 am ET
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2021.
Dec 21, 2021 04:01 pm ET
NanoString to Webcast Presentation from the 40th Annual JP Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 40th Annual JP Morgan Healthcare Conference to be held virtually from January 10th-13th, 2022.
Nov 11, 2021 06:00 am ET
NanoString Launches nCounter TCR Diversity Panel and Analysis Package at the 2021 Annual Meeting of the Society for Immunotherapy of Cancer
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® TCR Diversity Panel and companion cloud-based TCR analysis report created for use with the ROSALIND® platform. This new gene expression panel allows researchers to measure th
Nov 10, 2021 06:00 am ET
NanoString to Webcast Presentation from the Stifel 2021 Virtual Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Stifel 2021 Virtual Healthcare Conference.
Nov 09, 2021 04:01 pm ET
NanoString Releases Operating Results for Third Quarter of 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2021.
Nov 09, 2021 03:54 pm ET
NanoString Releases High-Resolution FFPE Tissue Dataset Generated Using New CosMx Spatial Molecular Imager
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first public release of data generated by the CosMx™ Spatial Molecular Imager (SMI). The data represents the first high-plex, single cell in situ dataset from formalin-fixed paraffin-embedded (FFPE) tissue samples and is accompanied by the simultaneous publication of a manuscript describing the CosMx SMI technology and performance.
Nov 03, 2021 06:00 am ET
NanoString's GeoMx Digital Spatial Profiler Used to Explore Loss of Smell Associated with COVID-19
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in the journal Cell using the GeoMx® Digital Spatial Profiler (DSP) and GeoMx Human Whole Transcriptome Atlas (WTA) to address one of the more perplexing symptoms of COVID-19: Anosmia or the loss of smell.
Oct 18, 2021 06:00 am ET
NanoString Unveils Spatial Organ Atlas During the American Society of Human Genetics (ASHG) Conference
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the Spatial Organ Atlas, an annotated reference dataset of spatially resolved whole transcriptomes, providing a foundational knowledge base for researchers to quickly discover how organs function in both healthy and disease states, using the GeoMx® Digital Spatial Profiler (DSP).
Oct 12, 2021 06:00 am ET
NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ADC Development Panel, a specialized gene expression tool for use in the rapidly expanding field of Antibody Drug Conjugates (ADCs). Created in collaboration with leading pharmaceutical and clinical scientists, this novel panel is designed to provide molecular insights into important biological questions and challenges of oncology therapies.
Oct 06, 2021 06:00 am ET
NanoString to Release Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release third quarter 2021 operating results after the close of the market on Tuesday, November 9, 2021. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Sep 09, 2021 04:00 pm ET
NanoString to Webcast Presentation from the Baird 2021 Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Baird 2021 Global Healthcare Conference.
Sep 01, 2021 04:00 pm ET
NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 19th Annual Morgan Stanley Global Healthcare Conference.
Aug 31, 2021 06:00 am ET
NanoString’s GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP), published in the journal Cell.
Aug 04, 2021 04:01 pm ET
NanoString Releases Operating Results for Second Quarter of 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2021.
Jul 08, 2021 06:00 am ET
NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release second quarter 2021 operating results after the close of the market on Wednesday, August 4, 2021. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Jun 22, 2021 06:00 am ET
NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics.
Jun 15, 2021 06:00 am ET
NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy (PICI) announced today that they are collaborating on an expansive molecular characterization project for cellular therapies. The collaboration will define the characteristics that make a cell therapy effective, providing a standardized approach to developing CAR-T regimens that may improve patient outcomes across all cancer types, especially solid tumors.
May 27, 2021 06:00 am ET
NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Virtual Healthcare Conference.
May 20, 2021 06:00 am ET
NanoString to Webcast Presentation from the UBS Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the UBS Global Healthcare Conference.
May 17, 2021 06:00 am ET
NanoString's GeoMx Mouse Whole Transcriptome Atlas Expands Leadership in Spatial Genomics by Enabling Genome-Wide RNA Profiling
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the Mouse Whole Transcriptome Atlas (WTA) for spatial analysis research using the GeoMx® Digital Spatial Profiler (DSP). This launch extends the GeoMx RNA portfolio, which combines the power of spatial biology and Next Generation Sequencing (NGS), to enable full transcriptome spatial RNA and high-plex protein analysis on the GeoMx DSP.
May 10, 2021 04:00 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021.
May 04, 2021 03:00 am ET
NanoString’s Digital Spatial Profiling Platform Used to Create Foundational Dataset Revealing Insights into COVID-19
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP) is to be published in the journal Nature. This paper describes using the GeoMx DSP to develop a foundational dataset to better understand the biological impact of SARS-CoV-2 (COVD-19) infection in human lungs, which may lead to the identification of new therapeutic interventions and prevention strategies.
Apr 08, 2021 06:00 am ET
NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of spatial biology abstracts that will be presented at the 2021 meeting of the American Association of Cancer Research (AACR), which will be held virtually from April 10 - 15, 2021.
Apr 06, 2021 06:00 am ET
NanoString to Release First Quarter 2021 Operating Results and Host Conference Call on Monday, May 10, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release first quarter 2021 operating results after the close of the market on Monday, May 10, 2021. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Mar 31, 2021 06:00 am ET
NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx® Digital Spatial Profiler have been published in Nature and Nature Communications. These papers describe the use of Digital Spatial Profiling (DSP) technology to investigate SARS-CoV-2 infection and drive diagnostic, prevention, and treatment strategies.
Mar 22, 2021 10:13 am ET
NanoString, Illumina Accelerator and Doloromics Announce GeoMx Digital Spatial Profiling Collaboration to Develop Novel Pain Therapeutics
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the company has awarded a Technology Access Program grant with Illumina Accelerator startup, Doloromics, focused on gaining a deeper understanding of chronic pain diseases by spatially characterizing the dorsal root ganglion (DRG). NanoString will partner with at least one startup from each global Illumina Accelerator funding cycle for a GeoMx® Digital Spatial Profiler (DSP) Technology Access Program grant.
Mar 09, 2021 06:00 am ET
NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of two new board members, Dr. Dana Rollison and Janet George, effective March 8, 2021.
Mar 01, 2021 04:01 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2020.
Mar 01, 2021 10:06 am ET
NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager. Under the program, a customer can submit tissue samples to NanoString to be analyzed using the 1000-plex RNA panel and receive a complete data package. Researchers interested in participating in NanoString’s Technology Access Program should contact the company at [email protected].
Feb 24, 2021 06:00 am ET
NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 41st Annual Cowen Healthcare Conference.
Feb 22, 2021 06:00 am ET
NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the Whole Transcriptome Atlas (WTA) for research using human tissue and the GeoMx® Digital Spatial Profiler (DSP). In addition, NanoString is introducing the WTA for research using mouse tissue through its GeoMx Technology Access Program (TAP). These launches extend the GeoMx Atlas portfolio, which combine the power of spatial biology and Next Generation Sequencing, to enable full transcriptome spatial RNA and high-plex p
Feb 17, 2021 06:00 am ET
NanoString to Webcast Presentation from the 10th Annual SVB Leerink Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 10th Annual SVB Leerink Global Healthcare Conference.
Feb 11, 2021 06:00 am ET
NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release fourth quarter and fiscal year 2020 operating results after the close of the market on Monday, March 1, 2021. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Feb 09, 2021 06:00 am ET
Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature Medicine that used NanoString’s GeoMx® Digital Spatial Profiler (DSP) and the new Whole Transcriptome Atlas (WTA) to profile sarcoma tissue. The research was led by a team from the Broad Institute in Cambridge, Massachusetts. The paper, entitled “Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma,” can be found here.(
Jan 10, 2021 03:00 pm ET
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2020.
Jan 06, 2021 12:14 pm ET
Nature Methods Selects Spatially-Resolved Transcriptomics as the Method of the Year for 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the journal Nature Methods has selected spatially-resolved transcriptomics as their prestigious Method of the Year for 2020. See article here:
Jan 04, 2021 04:01 pm ET
NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 39th Annual J.P. Morgan Virtual Healthcare Conference.
Dec 09, 2020 06:00 am ET
NanoString’s GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a new peer-reviewed study utilizing its GeoMx® Digital Spatial Profiler (DSP) platform to uncover new information in patients’ responses to SARS-CoV-2 infection. The study published in Nature Communications titled, “Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection,” revealed the spatial heterogeneity of patients’ immune responses based on GeoMx DSP profiling of active SARS-CoV-2 infection in the l
Dec 01, 2020 06:00 am ET
NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology
The spatial molecular imager combines the power of high-plex profiling with high-resolution imaging to enable the analysis of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact tissue samples. The platform utilizes the company’s advanced Hyb & Seq chemistry, which over the last 18 months has been optimized for in situ spatial analysis. The platform is capable of profiling RNA and protein within a single cell down to sub-cellular resolution in multiple tissue types. To date, prototype systems have imaged RNA from as many as 1,000+ genes simultaneo
Nov 18, 2020 04:01 pm ET
NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it will host an Investor and Analyst Day on Tuesday, December 1st. The event is scheduled to take place from 11:30am – 1:30pm Eastern time and will be conducted in a virtual format.
Nov 17, 2020 06:00 am ET
NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health & Science University (OHSU) for their development of novel GeoMx® Digital Spatial Profiler (DSP) protein assays to spatially profile breast cancer. These assays will be designed to enhance breast cancer tumor analysis and may inform clinical decision-making of patient treatment options. The work will be performed under the GeoMx Translational Leadership Network (GTLN), and the newly formed GeoMx Clinical Consortium, w
Nov 12, 2020 04:01 pm ET
NanoString to Present at the Stifel 2020 Virtual Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Stifel 2020 Virtual Healthcare Conference.
Nov 11, 2020 06:00 am ET
NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of more than 35 NanoString-related abstracts, including 11 spatial biology studies that used the GeoMx® Digital Spatial Profiler (DSP), which will be presented at the SITC 35th Annual Meeting.
Nov 09, 2020 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter of 2020.
Nov 09, 2020 06:00 am ET
NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of GeoMx® DSP Protein Assays for next generation sequencing (NGS) readout, enabling multi-analyte analysis for both nCounter® and NGS readout.
Nov 06, 2020 04:01 pm ET
NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 29th Annual Credit Suisse Healthcare Conference which is being held virtually.
Oct 13, 2020 04:01 pm ET
NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $230.0 million. The number of shares issued at closing included the exercise in full of the underwriters’ option to purchase 750,000 additional shares. Net proceeds to NanoString from the offering were approximately $215.7 mi
Oct 08, 2020 09:33 am ET
OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into
Oct 07, 2020 07:58 pm ET
NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the pricing of an upsized underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $200.0 million. The size of the offering was increased from the previously announced $150.0 million of shares of common stock offered. NanoString has granted to the underwriters of the offering a 30-day option to purchase up to an addition
Oct 06, 2020 04:18 pm ET
NanoString Technologies Announces Commencement of Public Offering of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common stock in an underwritten public offering pursuant to NanoString’s shelf registration statement. In connection with this offering, NanoString expects to grant the underwriters a 30-day option to purchase up to $22.5 million of additional shares of its common stock. NanoString intends to use the net proceeds of the offering for working capita
Oct 06, 2020 04:06 pm ET
NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today provided preliminary financial and operational highlights for the third quarter of 2020.
Oct 05, 2020 06:00 am ET
NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release third quarter 2020 operating results after the close of the market on Monday, November 9, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Sep 14, 2020 06:00 am ET
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the establishment of the GeoMx Premier Access Sites, a global service network that will provide access to the GeoMx Cancer Transcriptome Atlas and future GeoMx commercial assays. The company also announced the availability of the new GeoMx Whole Transcriptome Atlas through the Technology Access Program (TAP) for the GeoMx Digital Spatial Profiler (DSP). Together these initiatives provide expanded access to next generation sequencing readout on GeoMx DS
Sep 09, 2020 04:01 pm ET
NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Morgan Stanley Global Healthcare Conference.
Sep 09, 2020 06:00 am ET
NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN will pioneer the application of spatial biology in large translational research studies, developing and sharing standardized practices to facilitate collaboration between groups of researchers across multiple institutions. To date, the GTLN includes members of the GeoMx Breast Cancer Consortium, established in 2019, and the newly established GeoMx COVID-19 Consortium. NanoStri
Sep 03, 2020 04:01 pm ET
NanoString to Present at the 2020 Baird Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Baird Global Healthcare Conference.
Aug 10, 2020 04:01 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter of 2020.
Aug 06, 2020 06:00 am ET
Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler
MINNEAPOLIS and SEATTLE, Aug. 6, 2020 /PRNewswire/ -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets and NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced an expansion of their partnership to include compatibility with ACD's 21,000+ RNAscope probes and 10 qualified RNAscope probe combinations with GeoMx® Digital Spatial Profiler (DSP) and the recently launched GeoMx Cancer Transcriptome Atlas
Aug 06, 2020 06:00 am ET
NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets, today announced an expansion of their partnership to include compatibility with ACD’s 21,000+ RNAscope probes and 10 qualified RNAscope probe combinations with the GeoMx® Digital Spatial Profiler (DSP) and the recently launched GeoMx Cancer Transcriptome Atlas (CTA).
Aug 03, 2020 06:00 am ET
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the first GeoMx® Digital Spatial Profiler (DSP) product optimized for read-out on Next Generation Sequencing (NGS) technology from Illumina, the Cancer Transcriptome Atlas (CTA).
Jul 08, 2020 06:00 am ET
NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release second quarter 2020 financial results after the close of the market on Monday, August 10, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Jun 16, 2020 05:41 pm ET
NanoString Announces New Products to Advance COVID-19 Disease Research
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the availability of new solutions to study the immune response in COVID-19 disease research. As part of an expanding portfolio of infectious disease research solutions, the nCounter® Host Response Gene Expression Panel and COVID -19 Panel Plus spike-in provide a comprehensive analysis of the viral infection and immune response. New protein and RNA content available on the GeoMx® Digital Spatial Profiler enable high-plex analysis of key biological pathw
May 20, 2020 09:00 am ET
NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® Analysis System. The new analysis functionality is built into
May 14, 2020 04:00 pm ET
NanoString to Present at the UBS Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 UBS Global Healthcare Conference.
May 12, 2020 06:00 am ET
Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today highlighted several recent peer-reviewed publications that utilized the company’s GeoMx® Digital Spatial Profiler (DSP) to discover spatially-resolved biomarkers. GeoMx DSP is an integrated system comprised of hardware, software, and reagents, capable of being read out using either the nCounter Analysis System or Next-Generation Sequencing (NGS).
May 11, 2020 06:00 am ET
NanoString to Present at the Bank of America Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Bank of America Securities Health Care Conference.
May 07, 2020 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter of 2020.
Apr 15, 2020 09:00 am ET
Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the first publication utilizing the nCounter® platform and its leading gene expression panels for measuring immune response in COVID-19 research. Work published in the journal Cell Host & Microbe by a team of scientists from the Viral Research and Experimental Medicine Centre (ViREMiCS), a unit of the SingHealth Duke-NUS Academic Medical Centre (AMC), outline the differences in host immune response to SARS-CoV-2 infections in their publication t
Apr 06, 2020 04:01 pm ET
NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary operational and financial results for the quarter ended March 31, 2020, and outlined the company’s response to the COVID-19 pandemic and the ongoing impact on operations.
Mar 05, 2020 06:00 am ET
NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). NanoString also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $30 million aggregate principal amount of the notes. The offering of the notes was upsized from the originally anno
Mar 04, 2020 07:21 am ET
NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other factors, $175 million aggregate principal amount of convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). NanoString also intends to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $26.25 million aggregate principal amount of the notes
Feb 26, 2020 04:00 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today reported financial results for the fourth quarter and year ended December 31, 2019.
Feb 20, 2020 06:00 am ET
NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced ten scientific studies utilizing the GeoMx™ Digital Spatial Profiler (DSP) that will be showcased at the 2020 Advances in the Genome Biology and Technology (AGBT) conference being held at the JW Marriott in Marco Island, Florida. These studies span cancer translational research to neuroscience discovery applications, illustrating the platform’s flexibility and opportunity to spatially map distinct cell types and quantitate biological activity. NanoStri
Feb 18, 2020 06:00 am ET
NanoString to Present at the 40th Annual Cowen Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 40th Annual Cowen Healthcare Conference in Boston.
Feb 10, 2020 09:00 am ET
NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019 financial results after the close of the market on Wednesday, February 26, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Feb 06, 2020 08:00 am ET
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announce
Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced new data on the identification of the predictive biomarker to be...
Jan 15, 2020 01:28 pm ET
Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the publication of two peer-reviewed studies using the GeoMx™ Digital Spatial Profiler (DSP) in the journal Nature. The two independent papers published by groups at the MD Anderson Cancer Center and Lund University used GeoMx DSP for deep molecular profiling of immune cells critical for understanding response to immunotherapy in patients with metastatic melanoma.
Jan 12, 2020 06:00 pm ET
NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today provided preliminary operational and financial results for the fourth quarter and fiscal year ended December 31, 2019.
Jan 02, 2020 04:01 pm ET
NanoString to Present at the 38th Annual JP Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 38th Annual JP Morgan Healthcare Conference in San Francisco.
Dec 11, 2019 06:00 am ET
NanoString Announces the Creation of the GeoMx Breast Cancer Consortium
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the formation of the GeoMx™ Breast Cancer Consortium (GBCC).
Dec 03, 2019 05:00 pm ET
NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select nCounter-based diagnostic assets and rights to Veracyte Inc. for $50 million in cash and Veracyte stock, plus up to $10 million in cash upon satisfaction of future potential milestones.
Dec 03, 2019 06:00 am ET
Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a collaborative study with the Broad Institute of MIT and Harvard entitled “A rapid and accurate method to determine antibiotic susceptibilities based on simultaneous detection of genotype and phenotype” that demonstrates the potential for the Hyb & Seq™ technology to transform infectious disease testing. NanoString and the Broad Institute have entered into a non-exclusive license agreement for intellectual proper
Nov 25, 2019 04:01 pm ET
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston.
Nov 13, 2019 04:01 pm ET
NanoString to Present at the Stifel 2019 Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Stifel 2019 Healthcare Conference in New York City.
Nov 07, 2019 04:01 pm ET
NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the highlights of numerous abstracts demonstrating advances in understanding of immune response and cancer immunotherapy using the nCounter® and GeoMx™ Digital Spatial Profiler (DSP) platforms that will be presented at the 34th Annual Meeting of the Society of Immunotherapy for Cancer (SITC).
Nov 04, 2019 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2019.
Nov 04, 2019 06:00 am ET
NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the availability of its new GeoMx™ Cancer Transcriptome Atlas through the Technology Access Program (TAP) for the GeoMx Digital Spatial Profiler (DSP).
Nov 04, 2019 06:00 am ET
NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will support the Human Cell Atlas (HCA) initiative for high-plex, spatial quantitation of RNA and protein across a variety of tissue types. Under the terms of the agreement, HCA members and their insti
Oct 31, 2019 06:00 am ET
NanoString Appoints Don Kania, Ph.D. to its Board of Directors
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Don Kania, Ph.D. to its board of directors, effective October 30, 2019.
Oct 07, 2019 04:05 pm ET
NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release third quarter 2019 financial results after the close of trading on Monday, November 4, 2019. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Oct 04, 2019 04:30 pm ET
NanoString Reports Inducement Grant Under NASDAQ Listing Rules
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported, as required by NASDAQ Stock Market Rules, an equity inducement award to Mark Winham, the Company’s new Senior Vice President, Operations.
Oct 02, 2019 06:00 am ET
NanoString Appoints Mark Winham Senior Vice President of Operations
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Mark Winham as senior vice president of Operations effective October 2, 2019.
Sep 24, 2019 08:00 am ET
CareDx Adds HistoMap To Testing Portfolio
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced a...
Sep 23, 2019 06:00 am ET
NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for researchers to evaluate the human immune response following organ transplantation.
Aug 28, 2019 06:00 am ET
NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2019 Morgan Stanley...
Aug 19, 2019 06:00 am ET
NanoString to Present at the Baird 2019 Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Baird 2019 Global...
Aug 06, 2019 06:00 am ET
New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study in the journal Acta Neuropathologica that demonstrates the...
Jul 31, 2019 04:01 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2019. Second Quarter Financial Highlights Total...
Jul 30, 2019 09:29 am ET
NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays
NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString's new GeoMx Digital Spatial Profiler. GeoMx combines spatial and molecular profiling technologies by generating a whole...
Jul 23, 2019 03:20 pm ET
CORRECTING and REPLACING - Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
In a release issued yesterday by NanoString Technologies, Inc. (NASDAQ:NSTG) under the same headline, please note that in the third paragraph Dr. Justin Balko's title has been revised. Complete corrected text follows:  NanoString Technologies,...
Jul 22, 2019 04:01 pm ET
Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study in the journal Nature Medicine that demonstrates the capability...
Jul 15, 2019 06:00 am ET
NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a collaboration with the MODEL-AD consortium that has resulted in the development of two...
Jul 10, 2019 06:00 am ET
NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2019 financial results after the close of...
Jun 18, 2019 04:01 pm ET
Publication in the Journal Clinical Cancer Research Uses NanoString’s GeoMx Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a publication in the journal Clinical Cancer Research of a collaborative research study led...
May 30, 2019 04:01 pm ET
NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced commercial partnerships with three Contract Research Organizations (CROs), including...
May 15, 2019 06:00 am ET
NanoString to Present at the UBS Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the UBS Global Healthcare...
May 09, 2019 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2019. First Quarter Financial Highlights Total...
Apr 08, 2019 04:01 pm ET
NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2019 financial results after the close of...
Apr 04, 2019 05:00 am ET
Investor Expectations to Drive Momentum within Cisco, NanoString Technologies, Galapagos NV, A10 Networks, International Seaways, and Scholastic — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cisco Systems, Inc. (NASDAQ:CSCO), NanoString Technologies, Inc....
Apr 02, 2019 09:17 am ET
NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leica’s BOND RX Platforms for High Throughput Spatial Analysis
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a comarketing agreement to promote and provide technical support for a research workflow...
Apr 01, 2019 06:00 am ET
NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a commercial agreement with Abcam plc (AIM:ABC), a global innovator in life science reagents...
Mar 28, 2019 09:09 am ET
Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
MINNEAPOLIS, March 28, 2019 /PRNewswire/ -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, are partnering to accelerate the development of new tools for spatial genomics. The combined workflow that unites the RNAscope® reagent portfolio from Bio-Techne with NanoString's GeoMx™ RNA Assays enables researchers to molecularly guide their high
Mar 28, 2019 06:00 am ET
Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for...
Mar 27, 2019 06:00 am ET
NanoString Announces Commercial Launch of GeoMx Digital Spatial Profiler at the 2019 American Association of Cancer Research Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial availability of the GeoMx™ Digital Spatial Profiler during the American...
Mar 26, 2019 06:00 am ET
NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that a record number of studies enabled by the company’s nCounter® Analysis System and...
Mar 25, 2019 06:00 am ET
NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 5,175,000 shares of...
Mar 19, 2019 06:33 pm ET
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a...
Mar 18, 2019 04:18 pm ET
NanoString Technologies Announces Commencement of Public Offering of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its...
Mar 07, 2019 04:01 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2018 Operating Results and Provides 2019 Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2018. Fourth Quarter...
Mar 04, 2019 04:01 pm ET
NanoString to Present at the 39th Annual Cowen Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 39th Annual Cowen Healthcare...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.